{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:57:31Z","timestamp":1790715451401,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1013518"],"award-info":[{"award-number":["NRF-2022R1A2C1013518"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["NRF-2022R1A2C1013518"],"award-info":[{"award-number":["NRF-2022R1A2C1013518"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>NSAID-induced small intestinal injury is a clinically significant complication among chronic NSAID and aspirin users, yet effective treatment options remain limited. This systematic review evaluated natural products, functional foods, and probiotics for preventing or treating NSAID-induced small intestinal injury. PubMed, Embase, CENTRAL, and CNKI were searched from inception to January 2026 for randomized studies involving adults with NSAID- or aspirin-induced enteropathy assessed using capsule endoscopy or intestinal permeability testing. Risk of bias was assessed using RoB 2 and ROBINS-I. Due to substantial clinical and methodological heterogeneity, meta-analysis was not performed, and findings were synthesized narratively. Twenty-two studies were included: 21 randomized controlled trials and one quasi-randomized study. Geranylgeranylacetone demonstrated protective effects in three of four capsule endoscopy studies. Lactoferrin, zinc carnosine, and fish protein hydrolysate reduced indomethacin-induced intestinal hyperpermeability. Probiotic effects appeared outcome-dependent, with more consistent benefits observed for capsule endoscopy-based mucosal injury outcomes than for intestinal permeability outcomes. Among randomized trials, three were rated as having low risk of bias, 15 had some concerns, and three had high risk. Overall, preliminary evidence suggests that selected natural-origin interventions may protect against NSAID\/aspirin-induced small intestinal injury. However, because the certainty of evidence was generally low or very low, these findings should be interpreted as hypothesis-generating and require confirmation in larger, methodologically rigorous trials.<\/jats:p>","DOI":"10.3390\/antiox15070903","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:16:39Z","timestamp":1784650599000},"page":"903","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protective Effects of Natural Products, Functional Foods, and Probiotics on NSAID-Induced Small Intestinal Injury: A Systematic Review with Mechanistic Considerations of Oxidative Stress and Microbiome Modulation"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6304-1972","authenticated-orcid":false,"given":"Ji Hye","family":"Hwang","sequence":"first","affiliation":[{"name":"Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University, Seongnam 13120, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Kyung","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Korean Internal Medicine, College of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gtc.2010.08.010","article-title":"Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: Clinical picture, pathogenesis, and prevention","volume":"39","author":"Scarpignato","year":"2010","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhang, M., Xia, F., Xia, S., Zhou, W., Zhang, Y., Han, X., Zhao, K., Feng, L., Dong, R., and Tian, D. (2022). NSAID-associated small intestinal injury: An overview from animal model development to pathogenesis, treatment, and prevention. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.818877"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/MCG.0000000000001975","article-title":"Drugs effective for nonsteroidal anti-inflammatory drugs or aspirin-induced small bowel injuries: A systematic review and meta-analysis of randomized controlled trials","volume":"58","author":"Choe","year":"2024","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.gastro.2017.10.049","article-title":"Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs","volume":"154","author":"Bjarnason","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cgh.2015.10.022","article-title":"Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug\u2013induced small bowel injury: A randomized, placebo-controlled trial","volume":"14","author":"Washio","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/j.gastro.2005.03.020","article-title":"A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy","volume":"128","author":"Maiden","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-019-01657-8","article-title":"Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: A comprehensive review","volume":"55","author":"Watanabe","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.41.3.344","article-title":"Mitochondrial Damage: A Possible Mechanism of the \u201ctopical\u201d Phase of NSAID Induced Injury to the Rat Intestine","volume":"41","author":"Somasundaram","year":"1997","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/10715762.2014.928411","article-title":"The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury","volume":"48","author":"Handa","year":"2014","journal-title":"Free Radic. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0016-5085(97)70225-7","article-title":"Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation","volume":"112","author":"Reuter","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107670","DOI":"10.1016\/j.intimp.2021.107670","article-title":"Food antigens exacerbate intestinal damage and inflammation following the disruption of the mucosal barrier","volume":"96","author":"Ma","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.gtc.2009.03.007","article-title":"Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications","volume":"38","author":"Lanas","year":"2009","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2018.06.056","article-title":"Misoprostol heals small bowel ulcers in aspirin users with small bowel bleeding","volume":"155","author":"Kyaw","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2468-1253(18)30119-5","article-title":"Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"3","author":"Taha","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2016.12.007","article-title":"Rifaximin reduces the number and severity of intestinal lesions associated with use of nonsteroidal anti-inflammatory drugs in humans","volume":"152","author":"Scarpignato","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00535-013-0805-2","article-title":"A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and\/or non-steroidal anti-inflammatory drug induced small bowel injury","volume":"49","author":"Kurokawa","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000236032","article-title":"Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: A prospective randomized placebo-controlled double-blind cross-over study","volume":"80","author":"Niwa","year":"2009","journal-title":"Digestion"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Watari, I., Oka, S., Tanaka, S., Aoyama, T., Imagawa, H., Shishido, T., Yoshida, S., and Chayama, K. (2013). Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: A pilot randomized controlled study. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-108"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/sj.ejcn.1601727","article-title":"Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers","volume":"57","author":"Troost","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2036.2008.03783.x","article-title":"Clinical trial: Protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury","volume":"28","author":"Marchbank","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/gut.2006.099929","article-title":"Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes","volume":"56","author":"Mahmood","year":"2007","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2036.1999.00523.x","article-title":"Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans","volume":"13","author":"Hond","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00535-011-0410-1","article-title":"Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: A pilot randomized controlled study","volume":"46","author":"Endo","year":"2011","journal-title":"J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2019.05.008","article-title":"Bifidobacterium breve Bif195 protects against small-intestinal damage caused by acetylsalicylic acid in healthy volunteers","volume":"157","author":"Mortensen","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A risk of bias instrument for non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/00365520903453182","article-title":"Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage","volume":"45","author":"Shiotani","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.3748\/wjg.v20.i31.11012","article-title":"Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury","volume":"20","author":"Huang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2169\/internalmedicine.53.1572","article-title":"Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine","volume":"53","author":"Umegaki","year":"2014","journal-title":"Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.dld.2015.01.005","article-title":"Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: A prospective randomized study","volume":"47","author":"Xiong","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_34","first-page":"1024","article-title":"A randomized controlled trial of glutamine in the treatment of small intestinal mucosal injury in patients taking aspirin","volume":"19","author":"Chen","year":"2024","journal-title":"China Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bours, M.J.L., Bos, H.J., Meddings, J.B., Brummer, R.J.M., van den Brandt, P.A., and Dagnelie, P.C. (2007). Effects of oral adenosine 5\u2032-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: A randomized cross-over study. BMC Gastroenterol., 7.","DOI":"10.1186\/1471-230X-7-23"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MEG.0b013e328011093c","article-title":"Local effect of adenosine 5\u2032-triphosphate on indomethacin-induced permeability changes in the human small intestine","volume":"19","author":"Bours","year":"2007","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ganda Mall, J.-P., Fart, F., Sabet, J.A., Lindqvist, C.M., Nestestog, R., Hegge, F.T., Keita, \u00c5.V., Brummer, R.J., and Schoultz, I. (2020). Effects of dietary fibres on acute indomethacin-induced intestinal hyperpermeability in the elderly: A randomised placebo controlled parallel clinical trial. Nutrients, 12.","DOI":"10.3390\/nu12071954"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000452361","article-title":"Yogurt containing Lactobacillus gasseri mitigates aspirin-induced small bowel injuries: A prospective, randomized, double-blind, placebo-controlled trial","volume":"95","author":"Suzuki","year":"2017","journal-title":"Digestion"},{"key":"ref_39","first-page":"1014","article-title":"Preventive effect of Lactobacillus salivarius WB21 on small bowel injuries in subjects who take both NSAID and PPI: A randomized, double-blind, placebo-controlled trial","volume":"7","author":"Okamoto","year":"2019","journal-title":"U Eur. Gastroenterol. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/00365521.2022.2073184","article-title":"Lactobacillus complex capsules ameliorate aspirin-related small intestinal mucosal injury: A prospective, randomized, controlled clinical trial","volume":"57","author":"Chen","year":"2022","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wilms, E., Gerritsen, J., Smidt, H., Besseling-van der Vaart, I., Rijkers, G.T., Garcia Fuentes, A.R., Masclee, A.A.M., and Troost, F.J. (2016). Effects of supplementation of the synbiotic Ecologic\u00ae 825\/FOS P6 on intestinal barrier function in healthy humans: A randomized controlled trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167775"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"40128","DOI":"10.1038\/srep40128","article-title":"The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial","volume":"7","author":"Mujagic","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Judkins, T.C., Solch-Ottaiano, R.J., Ceretto-Clark, B., Nieves, C., Colee, J., Wang, Y., Tompkins, T.A., Caballero-Calero, S.E., and Langkamp-Henken, B. (2024). The effect of an acute aspirin challenge on intestinal permeability in healthy adults with and without prophylactic probiotic consumption: A double-blind, placebo-controlled, randomized trial. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-023-03102-w"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000106756","article-title":"Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70","volume":"75","author":"Yanaka","year":"2007","journal-title":"Digestion"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1440-1746.2000.02144.x","article-title":"Role of heat shock proteins in gastric mucosal protection","volume":"15","author":"Rokutan","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00535-010-0213-9","article-title":"Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury","volume":"45","author":"Omatsu","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.bpj.2009.09.030","article-title":"The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin","volume":"97","author":"Mir","year":"2009","journal-title":"Biophys. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.37.5.595","article-title":"Peptides and gastrointestinal mucosal integrity","volume":"37","author":"Playford","year":"1995","journal-title":"Gut"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000374106","article-title":"NSAID-induced small intestinal damage\u2014Roles of various pathogenic factors","volume":"91","author":"Takeuchi","year":"2015","journal-title":"Digestion"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.celrep.2019.03.054","article-title":"Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-Dependent mechanism","volume":"27","author":"Fachi","year":"2019","journal-title":"Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000452356","article-title":"Microbiota plays a key role in non-steroidal anti-inflammatory drug-induced small intestinal damage","volume":"95","author":"Otani","year":"2017","journal-title":"Digestion"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"16796","DOI":"10.1038\/s41598-019-52980-2","article-title":"High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17A","volume":"9","author":"Sugimura","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Scarpignato, C., Gatta, L., Zullo, A., and Blandizzi, C. (2016). Effective and safe proton pump inhibitor therapy in acid-related diseases\u2014A position paper addressing benefits and potential harms of acid suppression. BMC Med., 14.","DOI":"10.1186\/s12916-016-0718-z"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Maseda, D., and Ricciotti, E. (2020). NSAID-gut microbiota interactions. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01153"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1756283X17747780","DOI":"10.1177\/1756283X17747780","article-title":"The Lewis score or the capsule endoscopy Crohn\u2019s disease activity index: Which one is better for the assessment of small bowel inflammation in established Crohn\u2019s disease?","volume":"11","author":"Yablecovitch","year":"2018","journal-title":"Ther. Adv. Gastroenterol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/903\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:26:23Z","timestamp":1784651183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antiox15070903"],"URL":"https:\/\/doi.org\/10.3390\/antiox15070903","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}